| 摘要 |
<p>The present invention relates to pharmaceutical compositions comprising compounds of the Formula I, or a pharmaceutically acceptable salt thereof, and methods of selectively inhibiting or antagonizing the alphanubeta3 and/or the alphanubeta5 integrin without significantly inhibiting the alphanubeta6 integrin.</p> |
